HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perneczky, R. Articles by Kurz, A. Search for Related Content PubMed PubMed Citation Articles by Perneczky, R. Articles by Kurz, A.

Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia Rating

From the Department of Psychiatry and Psychotherapy (RP, KK, TG, JD, AK) and the Institute of Medical Statistics and Epidemiology (SW), Technische Universität München, Germany.

Objective: Although the clinical course of Alzheimer disease (AD) is gradual, it is useful for a number of reasons to distinguish between different levels of severity. The Clinical Dementia Rating (CDR) has demonstrated high validity and reliability for this purpose, but it requires a considerable amount of data to be collected both from the patient and from an informant. In the present study, the authors mapped Mini-Mental State Examination (MMSE) scores onto CDR categories to determine how well the MMSE performs as a surrogate of the CDR as a timesaving method of staging dementia.

Method: Eight hundred sixty-three probands, including 524 patients with probable AD, 92 patients with questionable dementia, and 247 with memory complaints but no objective cognitive impairment, were included. Cutoff scores were identified on one-half of the sample using a receiver operating characteristic analysis. The cutoff values were then applied to the other half of the sample, and the agreement between MMSE score ranges and CDR stages was determined by calculating Cohen’s kappa.

Results: The MMSE discriminated well between CDR stages 0.5, 1, 2, and 3 but performed poorly in the separation between CDR stages zero and 0.5. The MMSE ranges were 30 for no, 26–29 for questionable, 21–25 for mild, 11–20 for moderate, and 0–10 for severe dementia. Substantial agreement between the two instruments was obtained for the categories mild ( = 0.62, p <0.001, N = 115), moderate ( = 0.69, p <0.001, N = 114), and severe dementia ( = 0.76, p <0.001, N = 39), whereas the agreement was moderate for no ( = 0.44, p <0.001, N = 120) and only fair for questionable dementia ( = 0.28, p <0.001, N = 42).

Conclusion: The MMSE can be used as a surrogate measure for the CDR for the staging of dementia in AD.

Key Words: Dementia • severity • staging • MMSE • CDR

This article has been cited by other articles:

				S. E. O'Bryant, S. C. Waring, C. M. Cullum, J. Hall, L. Lacritz, P. J. Massman, P. J. Lupo, J. S. Reisch, R. Doody, and for the Texas Alzheimer's Research Consortium Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores: A Texas Alzheimer's Research Consortium Study Arch Neurol, August 1, 2008; 65(8): 1091 - 1095. [Abstract] [Full Text] [PDF]

				S. Kloppel, C. M. Stonnington, C. Chu, B. Draganski, R. I. Scahill, J. D. Rohrer, N. C. Fox, C. R. Jack Jr, J. Ashburner, and R. S. J. Frackowiak Automatic classification of MR scans in Alzheimer's disease Brain, March 1, 2008; 131(3): 681 - 689. [Abstract] [Full Text] [PDF]

				R. Perneczky, J. Hartmann, T. Grimmer, A. Drzezga, and A. Kurz Cerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment J Geriatr Psychiatry Neurol, June 1, 2007; 20(2): 84 - 88. [Abstract] [PDF]

				R Perneczky, A Drzezga, J Diehl-Schmid, G Schmid, A Wohlschlager, S Kars, T Grimmer, S Wagenpfeil, A Monsch, and A Kurz Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1060 - 1063. [Abstract] [Full Text] [PDF]